You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 10, 22 MAY 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Thyrotropin in Primary Hypothyroidism

A Possible Predictor of Optimal Daily Levothyroxine Dose in Primary Hypothyroidism

Udaya M. Kabadi, MD; Tad Jackson, MD

Arch Intern Med. 1995;155(10):1046-1048.


Abstract

Background
Pretreatment thyrotropin levels may be a reliable predictor of the optimal daily dose of levothyroxine sodium in patients with primary hypothyroidism. However, the older method of serum thyrotropin determination, with the reference range of less than 1 to 8 mU/L, has given way to a newer, supersensitive thyrotropin assay, with a reference range of 0.5 to 5.0 mU/L. Thus, at present, the previously established relationship between the levothyroxine dose and the pretreatment serum thyrotropin concentration may not be reliable in predicting the optimal daily dose of levothyroxine.

Methods
We reassessed the relationship between the optimal daily levothyroxine dose and the pretreatment serum thyrotropin concentration as determined by the newer assay in 192 consecutive patients with primary hypothyroidism referred to an endocrinology clinic over a period of 4 years.

Results
The optimal daily dose of levothyroxine sodium ranged from 25 to 225 µg, with most patients (65%) requiring 100 to 150 µg/d and a median dose of 125 µg. Multiple regression analysis documented a significant curvilinear correlation between the mean pretreatment serum thryrotropin concentration and the optimal daily levothyroxine dose for individual groups divided according to available tablet strengths (r=.994, P<<.001). A simple linear regression was also significant (r=.92, P<.001), although with an intercept much higher than the minimum levothyroxine sodium dose of 25 µg/d. However, the relationships markedly improved when the linear regressions were determined separately for two further subgroups at the median daily dose of 125 µg, providing equations to predict even the smallest optimal daily dose of levothyroxine.

Conclusion
Pretreatment thyrotropin levels determined by new assays may also provide a useful guideline in determining the optimal daily maintenance dose of levothyroxine in patients with primary hypothyroidism.

(Arch Intern Med. 1995;155:1046-1048)



Author Affiliations

From the Endocrine Section, Veterans Affairs Medical Center, Phoenix, Ariz, and the University of Arizona College of Medicine, Tucson.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.